Surgical Stapling Devices Market Analysis Report By Product (Powered, Manual), By Type (Disposable, Reusable), By End Use (Hospitals, Ambulatory Centers), By Region, And Segment Forecasts, 2018 - 2025

Industry Insights

The global surgical stapling devices market size was valued at around USD 3.96 billion in 2017 and is expected to register a CAGR of 8.13% over the forecast period. The market is expected to exhibit lucrative growth opportunities in the coming years owing to increasing preference for staples over sutures. With technological advances, several market players are commercializing staplers used for endoscopic surgeries. These devices find application across various branches of medicine, such as gynecology, thoracic, and gastrointestinal-related surgeries as well as tissue and wound management procedures.

Initially, sutures were widely used for wound closure. However, introduction of staples has gradually outpaced suture demand due to several advantages. Apart from being a tedious process, sutured sites may exhibit wound leakage and separation, whereas surgical staplers offer better speed, accuracy, and efficient wound closure.

Demand for surgical stapling is expected to increase owing to rise in bariatric procedures and implementation of advanced technologies to perform endoscopic procedures. Introduction of powered surgical devices will further support market growth.

In developing countries such as India and China, surgical staplers are widely employed for bariatric surgeries. Covidien plc and Ethicon Endo-Surgery, Inc. offering titanium stomach staples, reported that obesity-related surgeries in India doubled in 2013, and hence, the number of bariatric procedures has increased in the country. This has greatly benefited the market for surgical stapling devices.

Product Insights

Conventionally, manual surgical staplers were used along with scalpels, forceps, and scissors. With soaring demand and increasing frequency of surgeries, powered stapling devices are expected to be the fastest growing product segment over the forecast period. These powered devices address the problem of fatigue in doctors due to high procedure volume in hospital emergency wards. Moreover, laparoscopic surgeries are typically labor-intensive, requiring accuracy while execution within restricted anatomical spaces. The prime advantage offered by powered stapling is ease of wound closure without the requirement of manual firing force.

Introduction of novel technologies such as biowelding and cold plasma, used to seal wounds without scars or stitches, is likely to create demand for electrosurgical devices in future and emerge as an alternative to sealants, staples, and sutures. It is approved in Europe and is used in skin grafting.

Type Insights

Based on type of material used, the surgical stapling devices market can be segmented into disposable or reusable. Medical grade plastic is used in disposable devices while reusable devices are made from stainless steel used for biomedical applications. Both types use disposable cartridges.

The disposable segment is expected to grow at a rapid rate over the forecast period as a result of heightened concerns over communicable infections. The Centers for Disease Control and Prevention (CDC) promotes use of disposable devices and provides protocols to prevent spread of pathogens. Regulatory authorities such as the U.S. Food and Drug Administration (FDA) have also stated some measures to ensure that set protocols for sterilization of medical devices are strictly followed in order to avoid infections.

Lifestyle changes have led to increase in people suffering from obesity, especially in developed countries such as U.S. This has resulted in increase in demand for bariatric or weight loss procedures, ultimately increasing the application of stapling equipment. For instance, approximately 113,000 bariatric surgeries are performed every year in U.S. alone. The trend of opting for bariatric surgery is gaining grounds in developing countries too. India is one of the fastest growing markets for bariatric procedures, with an impetrating supply of 10,000 staplers every year.

End-use Insights

By end use, the market is bifurcated into hospitals and ambulatory centers. Hospitals was identified as the largest end-use segment in 2017 whereas ambulatory centers is anticipated to display the highest growth rate over the forecast period. The steady growth of the ambulatory centers segment can be attributed to factors such as scarce economic resources and shortage of hospital beds, especially in underdeveloped and developing economies.

A major trend in hospitals suggests a shift toward clinical efficiency models, which includes introduction of robotic technology in surgery. Robotic surgeries improve the outcome of minimally invasive surgeries. The hospitals segment is expected to retain its dominance over the forecast period owing to favorable reimbursement scenario for bariatric surgeries. This is available solely for inpatients and hospital outpatients, while ambulatory centers are not covered under this code.

Regional Insights

In 2017, North America held the largest market share owing to use of advanced technologies and noninvasive methods during surgery. Increasing number of total surgeries performed is also a crucial driving factor. Other reasons for the region’s dominant market share are high obesity rate, local presence of global players, and FDA approval for noninvasive surgeries. With recent developments in minimally invasive surgeries, special devices are designed for laparoscopic and thoracoscopic surgeries, which includes use of surgical stapling equipment. It has become the responsibility of surgeons to acquire prerequisite knowledge of stapling devices.

Asia Pacific is the fastest growing sector, with a CAGR of over 9.0% during the forecast period due to presence of a large patient pool in economies such as India, China, and Japan. In 2011, surgical staplers were categorized under “drugs” and were regulated under the Drugs and Cosmetics Act in India because of increasing demand and use. Implementation of this act rendered strict regulations for the manufacturing and distribution of surgical staplers.

Increase in surgeries, coupled with rising healthcare expenditure and growing awareness about their use is expected to drive demand in the region. Key players are also investing in this region to expand their footprint. Initiatives such as those taken by Johnson & Johnson Medical, India, to train 8,000 doctors in advanced surgical products, including noninvasive surgical staples, are expected to propel the regional market.

Surgical Stapling Devices Market Share Insights

Some key industry contributors are Covidien plc; Ethicon Endo-Surgery, Inc.; Cardica, Inc.; Zimmer Holdings, Inc.; Stryker Corporation; Smith & Nephew plc; Conmed Corporation; and CareFusion Corporation. Ethicon, Inc.; Covidien plc (Medtronic plc); and Stryker Corporation were the most attractive participants in the market in 2017.

In March 2017, Ethicon announced results of retrospective studies conducted to compare two products: Ethicon’s ECHELON FLEX Powered Staplers and Medtronic’s ENDO GIA Manual Staplers. The results were published in The Journal of Medical Economics and showed that Ethicon’s product was associated with economic and clinical benefits and lower rate of bleeding complications. In February 2017, Medtronic launched its new stapling system, Signia Stapling System. This was the latest addition to the company’s minimally invasive system product portfolio.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global surgical stapling devices market report based on product, type, end use, and region:

• Product Outlook (Revenue, USD Million, 2014 - 2025)

  • Powered

  • Manual

• Type Outlook (Revenue, USD Million, 2014 - 2025)

  • Disposable

  • Reusable

• End Use Outlook (Revenue, USD Million, 2014 - 2025)

  • Hospitals

  • Ambulatory Centers

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • France

    • Germany

    • United Kingdom

    • Spain

    • Italy

    • Netherlands

    • Switzerland

    • Belgium

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Turkey

    • Saudi Arabia

    • Israel